KYTX icon

Kyverna Therapeutics
KYTX

Overview Fund Activity

78 hedge funds and large institutions have $71.4M invested in Kyverna Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
-9
Holders Change %
-10.34%
% of All Funds
1.05%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
29
Reduced
24
Closed
24
Calls
$327K
Puts
–
Net Calls
+$327K
Net Calls Change
+$327K

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.84M
2
Millennium Management
Millennium Management
New York
+$658K
3
TD Asset Management
TD Asset Management
Ontario, Canada
+$497K
4
Jane Street
Jane Street
New York
+$269K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$245K

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$3.57M
2
BlackRock
BlackRock
New York
-$3.51M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.05M
4
State Street
State Street
Massachusetts
-$870K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$849K
Name Holding Trade Value Shares
Change 		Shares
Change %
Jones Financial Companies
101
Jones Financial Companies
Missouri
– -$162 -81 Closed
RIL
102
Rothschild Investment LLC
Illinois
– -$97 -50 Closed
1 2 3 4
5